hyaluronidase

Key facts

INN

hyaluronidase

Brand

VITRASE

Route

INJECTION

Formulation

INJECTABLE

Originator

Amphastar Pharmaceuticals

Related patents

patent

US 12178860

Hyaluronidase enzyme formulations for high volume administration

Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11723959

Preparation of mammalian oocyte for fertilization via a soluble human PH20 hyalu

Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10898551

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, us

Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10328130

Modified hyaluronidases and uses in treating hyaluronan-associated diseases and

Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10286044

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, us

Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 9677062

Hyaluronidase and factor VIII compositions

Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 9677061

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, us

Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 9562223

Methods for reducing intraocular pressure by administering a soluble hyaluronida

Expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is hyaluronidase?

hyaluronidase (VITRASE), is a pharmaceutical active ingredient, associated with Amphastar Pharmaceuticals, with approved status in the US.

What is the brand name for hyaluronidase?

VITRASE is a marketed brand name for hyaluronidase. Check FDA Drugs@FDA for the current US label holder.